AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -20.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $5 | +25.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4 | 0.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4 | -99.9% | 157 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | 0.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | -20.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | 0.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | -28.6% | 157 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | -22.2% | 157 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $9,000 | +12.5% | 157 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | +14.3% | 157 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $7,000 | +40.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $5,000 | -37.5% | 157 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $8,000 | +33.3% | 157 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | -14.3% | 157 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $7,000 | +40.0% | 157 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $5,000 | -37.5% | 157 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $8,000 | -27.3% | 157 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $11,000 | +57.1% | 157 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $7,000 | -41.7% | 157 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $12,000 | -7.7% | 157 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $13,000 | 0.0% | 157 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $13,000 | +44.4% | 157 | 0.0% | 0.01% | +66.7% |
| Q4 2017 | $9,000 | -10.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | +25.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $8,000 | -11.1% | 157 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $9,000 | +28.6% | 157 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $7,000 | -12.5% | 157 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $8,000 | +14.3% | 157 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $7,000 | +16.7% | 157 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $6,000 | -40.0% | 157 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $10,000 | -9.1% | 157 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $11,000 | -35.3% | 157 | 0.0% | 0.01% | -30.0% |
| Q2 2015 | $17,000 | +13.3% | 157 | 0.0% | 0.01% | +11.1% |
| Q1 2015 | $15,000 | – | 157 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
| Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
| Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
| HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
| Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
| Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
| Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
| Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |